Fig. 1

Analysis of the effect of 34-mer derived peptides on the VEGF-induced RPMI8226 cell proliferation. a Sequence diagram of the peptides derived from the 34-mer. b-e VEGF-induced cell proliferation was measured by an MTT assay. Cells were treated with 10 ng/ml VEGF in the presence of 25 μM peptide for 24 h. The MTT value of peptide solvent-treated RPMI8226 cells was set at 100%. Results represent the mean ± SD from three independent experiments. ^aP < 0.05 versus solvent. ^bP < 0.001, ^cP < 0.0001, ^dP < 0.00002 and ^eP < 0.00004 versus VEGF treatment